Evaluation of historical control data in carcinogenicity studies

被引:34
作者
Greim, H
Gelbke, HP
Reuter, U
Thielmann, HW
Edler, L
机构
[1] Tech Univ Munich, Inst Toxicol & Environm Hyg, D-85354 Freising Weihenstephan, Germany
[2] BASF AG, Inst Toxicol, D-67063 Ludwigshafen, Germany
[3] German Canc Res Ctr, D-69120 Heidelberg, Germany
关键词
carcinogenicity; historical control data; long-term animal studies;
D O I
10.1191/0960327103ht394oa
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Results obtained in long-term carcinogenicity studies with animals should be evaluated, first and foremost, by statistical comparisons of the data obtained from the treated group with that from the concurrent control group. Often the results are compared with data from so-called historical control groups in order to take variations in the incidences of spontaneous tumours into account. Because historical control data change in the course of time and for a variety of reasons, certain requirements must be met before they may be used in the evaluation of the results of long-term studies. The present paper discusses potential sources of variability of tumour incidences in untreated animals, presents databanks for historical control data, mentions the factors that affect tumour incidences in untreated animals and describes biostatistical data evaluation. Finally, details are given of the criteria used by the DFG Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area to decide whether historical control data may be applied. These include the requirement that the historical control data were obtained with animals of the same species and strain and from the same breeder. The data were obtained in the same laboratory, the study design, experimental methods and assessment criteria were the same, and the studies used for the comparison were carried out within a limited time window. Historical control data that have not been published may be used provided they fulfil the above criteria and have been made available in sufficient detail to be comprehensible.
引用
收藏
页码:541 / 549
页数:9
相关论文
共 66 条
[1]  
[Anonymous], 1982, Fundam Appl Toxicol, V2, P101
[2]  
[Anonymous], [No title captured]
[3]   EFFECTS OF TREATMENT-INDUCED MORTALITY AND TUMOR-INDUCED MORTALITY ON TESTS FOR CARCINOGENICITY IN SMALL SAMPLES [J].
BAILER, AJ ;
PORTIER, CJ .
BIOMETRICS, 1988, 44 (02) :417-431
[4]   PRENEOPLASTIC LESIONS AS END-POINTS IN CARCINOGENICITY TESTING .1. HEPATIC PRENEOPLASIA [J].
BANNASCH, P .
CARCINOGENESIS, 1986, 7 (05) :689-695
[6]  
BANNASCH P, 1997, MONOGRAPHS PATHOLOGY, P3
[7]  
*BOARD SCI COUNS N, 1984, REP NTP AD HOC PAN C
[8]  
BOMHARD E, 1986, J ENVIRON PATHOL TOX, V7, P35
[9]   Quality review procedures necessary for rodent pathology Databases and toxicogenomic studies: The National Toxicology Program experience [J].
Boorman, GA ;
Haseman, JK ;
Waters, MD ;
Hardisty, JF ;
Sills, RC .
TOXICOLOGIC PATHOLOGY, 2002, 30 (01) :88-92
[10]   Classification of cystic keratinizing squamous lesions of the rat lung: Report of a workshop [J].
Boorman, GA ;
Brockmann, M ;
Carlton, WW ;
Davis, JMG ;
Dungworth, DL ;
Hahn, FF ;
Mohr, U ;
Reichhelm, HBR ;
Turusov, VS ;
Wagner, BM .
TOXICOLOGIC PATHOLOGY, 1996, 24 (05) :564-572